Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation https://www.biorxiv.org/content/10.1101/2023.03.30.534894v1?med=mas
Vangl2 suppresses NF-κB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation https://www.biorxiv.org/content/10.1101/2023.03.30.534894v1?med=mas